Non-invasive Imaging of Human Coronary Atherothrombosis

Medicine and Dentistry

1. Fluorine-18 100%
2. Inpatient 66%
3. Patient 64%
4. Myocardial Infarction 60%
5. Positron Emission Tomography 50%
6. Coronary Artery Disease 42%
7. Plaque 42%
8. Coronary Computed Tomography Angiography 38%
9. Manganese 32%
10. Computed Tomography Angiography 31%
11. Magnetic Resonance Imaging 30%
12. Sodium Fluoride 29%
13. Thrombus 25%
14. Isotopes of Calcium 25%
15. Association 24%
16. Positron Emission Tomography-Computed Tomography 23%
17. Disease Activity 23%
18. Aortic Valve 23%
19. Cardiovascular Disease 22%
20. Computed Tomography 21%
21. Coronary Artery 21%
22. Analysis 19%
23. Microcalcification 19%
24. Computer Assisted Tomography 18%
25. Atherosclerotic Plaque 18%
26. Brain 17%
27. Brain Ischemia 16%
28. Mitochondrial Membrane Transport Protein 16%
29. Assessment 15%
30. Disease Exacerbation 15%
31. Cardiac Troponin 15%
32. Tissues 15%
33. Heart 14%
34. Diagnosis 14%
35. Aortic Stenosis 13%
36. Degeneration 13%
37. Thrombosis 13%
38. Coronary Angiography 13%
39. Hazard Ratio 13%
40. Age 13%
41. Therapeutic Procedure 12%
42. Radioactive Tracer 12%
43. Stenosis 11%
44. Transient Ischemic Attack 11%
45. Health Care Cost 11%
46. Cardiovascular Risk 11%
47. Enalapril Maleate 10%
48. Apelin 10%
49. Thorax Pain 10%
50. Cardiovascular System 9%
51. Mortality 9%
52. Predictor 9%
53. Serositis 9%
54. Death 8%
55. Accuracy 8%
56. Acute Coronary Syndrome 8%
57. Myocardium 8%
58. Fibrosis 8%
59. Atherosclerosis 8%
60. Cardiac Fibrosis 8%
61. Heart Valve Bioprosthesis 7%
62. Infarction 7%
63. Carotid Artery 7%
64. Troponin I 7%
65. Fluoride 7%
66. Kidney 7%
67. Artery Thrombosis 7%
68. Echocardiography 7%
69. Ischemic Heart Disease 6%
70. Stable Angina Pectoris 6%
71. Atheroma 6%
72. Prevalence 6%
73. Disease Severity 6%
74. Troponin 6%
75. Morbidity 6%
76. Macrophage 6%
77. Deterioration 6%
78. Cardiac Computed Tomography 6%
79. Protein 6%
80. Instability 6%
81. Chronic Kidney Disease 6%
82. Follow up 6%
83. Multimodality Imaging 6%
84. Protein Expression 6%
85. Cardiac Magnetic Resonance Imaging 6%
86. Man 6%
87. PET-CT 5%
88. Adipose Tissue 5%
89. Fluorodeoxyglucose F 18 5%
90. Molecular Imaging 5%
91. Oxygen Supply 5%
92. Autoradiograph 5%
93. Risk Stratification 5%
94. Molecular Disease 5%
95. Monocyte 5%
96. Prospective Cohort Study 5%
97. Heart Disease 5%
98. Lipoprotein 5%
99. Serum 5%
100. Thoracic Aorta 5%
101. Anthracycline 5%
102. Health Care Outcome 5%
103. Somatostatin Receptor 5%
104. Aortic Valve Disease 5%
105. Cardiology 5%
106. Reproducibility 5%
107. Fatty Liver 5%
108. Angiography 5%
109. Insulin Dependent Diabetes Mellitus 5%
110. Ejection Fraction 5%
111. Pulmonary Embolism 5%
112. Image Registration 5%
113. Bypass 5%
114. Pancreatic Islet 5%
115. Angina Pectoris 5%
116. Macrophage Polarization 5%
117. Takotsubo Cardiomyopathy 5%
118. Cardiotoxicity 5%
119. Signal-to-Noise Ratio 5%
120. Electrocardiogram 5%
121. Kidney Function 5%
122. Syndrome 5%
123. C57BL/6 5%
124. Volunteer 5%
125. Coronavirinae 5%
126. Morphology 5%
127. Drug Megadose 5%
128. Vasculitis 5%
129. Pain 5%
130. Rapid Assessment 5%
131. Cost-Effectiveness Analysis 5%
132. Polyethylene Terephthalate 5%
133. Acute Heart Infarction 5%
134. Male 5%